A clinical trial to study the beneficial effects of the drug Rupatadine in Low Back Pai
Phase 3
Completed
- Conditions
- Health Condition 1: M791- Myalgia
- Registration Number
- CTRI/2019/06/019845
- Lead Sponsor
- SRM Institute of Science and Technology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Age group 18-60 years
2. Subjects with Chronic Low Back Pain more than three months, Visual analog scale more than 40 mm
3. Both genders
4. Patients willing to give consent
Exclusion Criteria
1. History of acute fracture
2. History of malignancy or neurological deficit or severe leg pain mandating surgery
3. History of lumbar disc herniation or spinal stenosis
4. History of fibromyalgia or spinal surgery
5. History of recent trauma or injury
6. History of alcohol or narcotic abuse
7. History of Peptic ulcer disease or hepatic and renal dysfunction
8. History of heart surgery
9. History of Allergy to Aceclofenac CR or H1 antagonists
10. Pregnant,lactating women
11. Psychiatric disorders
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain relief to be assessedTimepoint: at the baseline, at second week, at the end of each month for two months using Visual Analog Pain Score
- Secondary Outcome Measures
Name Time Method Disability and Quality of Life to be assessed by Oswestry Disability Index questionnaire,WHOQOLBREF questionnaire respectivelyTimepoint: at the baseline and at the end of the each month for two months